CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 149 filers reported holding CARA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,574,000 | -20.2% | 434,527 | -32.8% | 0.14% | -44.8% |
| Q3 2020 | $8,234,000 | -46.6% | 647,082 | -28.2% | 0.26% | -52.3% |
| Q2 2020 | $15,419,000 | +32.7% | 901,714 | +2.5% | 0.55% | +1.5% |
| Q1 2020 | $11,623,000 | -3.9% | 879,858 | +17.2% | 0.54% | +28.0% |
| Q4 2019 | $12,093,000 | -7.0% | 750,680 | +5.5% | 0.42% | -10.0% |
| Q3 2019 | $13,005,000 | -36.5% | 711,411 | -25.4% | 0.47% | -28.2% |
| Q2 2019 | $20,490,000 | +168.8% | 953,006 | +58.7% | 0.65% | +81.6% |
| Q4 2018 | $7,624,000 | +10065.3% | 600,342 | +69.1% | 0.36% | +7080.0% |
| Q2 2018 | $75,000 | -98.1% | 354,986 | +5.2% | 0.01% | -97.9% |
| Q1 2018 | $3,992,000 | +144.9% | 337,486 | +165.8% | 0.24% | +105.1% |
| Q4 2017 | $1,630,000 | – | 126,952 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,304,603 | $18,617,000 | 2.04% |
| RHO CAPITAL PARTNERS INC | 1,499,058 | $21,392,000 | 1.96% |
| DAFNA Capital Management LLC | 315,000 | $4,495,000 | 0.94% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 432,178 | $6,167,000 | 0.72% |
| Altium Capital Management LP | 150,000 | $2,141,000 | 0.50% |
| Cypress Capital Management LLC (WY) | 16,743 | $239,000 | 0.18% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 674,846 | $9,630,000 | 0.18% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 73,902 | $1,055,000 | 0.16% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,000,000 | $28,540,000 | 0.12% |
| FIRST QUADRANT LLC/CA | 71,223 | $1,016,000 | 0.12% |